RxNorm Semantic Concepts Index - 234
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "234".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 23405 | dipipanone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 23405 | dipipanone | Designated preferred name (PT) | NO | |
RxCUI: 23405 | dipipanone | Full form of descriptor (FN) | NO | |
RxCUI: 23405 | dipipanone | Designated preferred name (PT) | NO | |
RxCUI: 23405 | dipipanone | Full form of descriptor (FN) | NO | |
RxCUI: 23410 | Dipivefrine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 23410 | Dipivefrine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 23410 | Dipivefrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 23410 | Dipivefrine | Designated preferred name (PT) | NO | |
RxCUI: 23410 | Dipivefrine | Designated preferred name (PT) | NO | |
RxCUI: 23410 | Dipivefrine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 23410 | Dipivefrine | Full form of descriptor (FN) | NO | |
RxCUI: 23410 | Dipivefrine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 23410 | Dipivefrine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 23410 | Dipivefrine | Full form of descriptor (FN) | NO | |
RxCUI: 23419 | Dipropizine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 23419 | Dipropizine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 23419 | Dipropizine | Designated preferred name (PT) | NO | |
RxCUI: 23419 | Dipropizine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 23419 | Dipropizine | Full form of descriptor (FN) | NO | |
RxCUI: 23420 | dipropylacetamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 23420 | dipropylacetamide | Designated preferred name (PT) | NO | |
RxCUI: 23420 | dipropylacetamide | Full form of descriptor (FN) | NO | |
RxCUI: 23437 | dirithromycin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 23437 | dirithromycin | Designated preferred name (PT) | NO | |
RxCUI: 23437 | dirithromycin | Full form of descriptor (FN) | NO | |
RxCUI: 23437 | dirithromycin | Designated preferred name (PT) | NO | |
RxCUI: 23437 | dirithromycin | Full form of descriptor (FN) | NO | |
RxCUI: 2344 | Chloral hydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2344 | Chloral hydrate | Designated preferred name (PT) | NO | |
RxCUI: 2344 | Chloral hydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2344 | Chloral hydrate | Designated preferred name (PT) | NO | |
RxCUI: 2344 | Chloral hydrate | Full form of descriptor (FN) | NO | |
RxCUI: 23441 | Discadenine synthase | Designated preferred name (PT) | NO | |
RxCUI: 23441 | Discadenine synthase | Full form of descriptor (FN) | NO | |
RxCUI: 234416 | Lanthanum carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 234416 | Lanthanum carbonate | Designated preferred name (PT) | YES | |
RxCUI: 234416 | Lanthanum carbonate | Full form of descriptor (FN) | YES | |
RxCUI: 234416 | Lanthanum carbonate | Designated preferred name (PT) | YES | |
RxCUI: 234416 | Lanthanum carbonate | Full form of descriptor (FN) | YES | |
RxCUI: 234449 | tositumomab/iodine (131I) tositumomab | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 234449 | tositumomab/iodine (131I) tositumomab | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 23454 | Disophenol | Designated preferred name (PT) | NO | |
RxCUI: 23454 | Disophenol | Full form of descriptor (FN) | NO | |
RxCUI: 23459 | Product containing disperse yellow 3 (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 23459 | Product containing disperse yellow 3 (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 23459 | Product containing disperse yellow 3 (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 23459 | Product containing disperse yellow 3 (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2346 | Chlorambucil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2346 | Chlorambucil | Designated preferred name (PT) | YES | |
RxCUI: 2346 | Chlorambucil | Full form of descriptor (FN) | YES | |
RxCUI: 2346 | Chlorambucil | Designated preferred name (PT) | YES | |
RxCUI: 2346 | Chlorambucil | Full form of descriptor (FN) | YES | |
RxCUI: 23468 | N-Sulfoglucosamine-6-sulfatase | Designated preferred name (PT) | NO | |
RxCUI: 23468 | N-Sulfoglucosamine-6-sulfatase | Full form of descriptor (FN) | NO | |
RxCUI: 234776 | Raucaffricine beta-glucosidase | Designated preferred name (PT) | NO | |
RxCUI: 234776 | Raucaffricine beta-glucosidase | Full form of descriptor (FN) | NO | |
RxCUI: 2348 | Chloramphenicol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2348 | Chloramphenicol | Designated preferred name (PT) | YES | |
RxCUI: 2348 | Chloramphenicol | Full form of descriptor (FN) | YES | |
RxCUI: 2348 | Chloramphenicol | Designated preferred name (PT) | YES | |
RxCUI: 2348 | Chloramphenicol | Full form of descriptor (FN) | YES | |
RxCUI: 234841 | Microtubule-associated protein 2 kinase | Designated preferred name (PT) | NO | |
RxCUI: 234841 | Microtubule-associated protein 2 kinase | Full form of descriptor (FN) | NO | |
RxCUI: 234841 | Microtubule-associated protein 2 kinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 234841 | Microtubule-associated protein 2 kinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2349 | Chloramphenicol acetyltransferase | Designated preferred name (PT) | NO | |
RxCUI: 2349 | Chloramphenicol acetyltransferase | Full form of descriptor (FN) | NO |